Pharma leaders rate ability to act on diagnostic insights just 5.2/10, Diaceutics survey finds

Wait 5 sec.

Pharmaceutical companies are struggling to translate diagnostic intelligence into coordinated action that helps eligible patients reach appropriate treatment, according to new research from intelligence and engagement company, Diaceutics.